Cancer is a big concern for firefighters in San Antonio. Firefighting is classified as a known human carcinogen by the International Agency for Research on Cancer. Occupational cancer has become the leading cause of death among firefighters. Studies have shown that firefighters face a 9% higher risk of being diagnosed with cancer and a 14% higher risk of dying from cancer compared to the general U.S. population. Within the San Antonio Fire Department (SAFD), more than 70 firefighters have been diagnosed with cancer in the past 10 years, including leukemia to multiple myeloma and cancers of the brain, thyroid, colon, prostate, and testicles. Many cases also go unreported. To help reduce the cancer risk among firefighters and emergency medical services personnel, SAFD, UT Health ...
Dr. Amelie G. Ramirez, leader of Salud America! and the Institute for Health Promotion Research at UT Health San Antonio, joined Coastal Living TV in Corpus Christi, Texas, to share how cancer survivors can join the Avanzando Caminos study. Avanzando Caminos is a study that aims to help cancer survivors. The study aims to enroll 1,500 Latino cancer survivors in South Texas and 1,500 more in Miami to help unpack the behavioral, mental, biological, and medical influences on life after cancer. As part of the study, volunteers share their cancer journeys. "So far, the individuals who've participated have been really grateful. They said, 'I've never had a chance to tell my story about what I went through,'" Ramirez said. "It will help us take a deeper look into how we can help our ...
Cancer screening can save lives by detecting cancer early, when it’s most treatable or before it starts. Watch a webinar about cancer screening at UT Health San Antonio’s webinar, “The Thing that Could Save Your Life,” which took place at 1 p.m. Central on March 4, 2025. The webinar featured experts from the Mays Cancer Center at UT Health San Antonio, Genentech, and a cancer survivor, who explored available cancer screenings and how to access them in South Texas and beyond. Panelists examined common myths and barriers to routine cancer screening, including the non-medical drivers of health, and strategies to overcome those myths and barriers. Panelists also shared other cancer prevention strategies from risk reduction and participating in clinical trials. This is a ...
From 2009 and 2019, cancer was the top cause of death in the US for Latinos. Now, while new data show that cancer has become the second-leading cause of death in Latinos, only slightly behind heart disease, cancer remains a big threat to Latino health. Every year, heart disease and cancer cause 17% of Latino deaths in the US, according to the American Cancer Society’s Cancer Facts & Figures for Hispanic/Latino People 2024-2026 report. Let’s dive into the key highlights of the report and go over some of the reasons why Latinos are disproportionately affected by cancer.
Cancer Incidence Among Latinos
The American Cancer Society estimates 195,300 cancer cases would be diagnosed in Latinos in 2024 with another 50,400 Latino individuals dying from the disease. Among the ...
Cancer is a big health issue for Latinos and all people. That’s why Dr. Amelie Ramirez, director of Salud America! and the Institute for Health Promotion Research at UT Health San Antonio, partnered with the Mays Cancer Center to create the Advancing the Science of Cancer in Latinos (ASCL) biennial conference. Read the proceedings from the 2018, 2020, and 2022 ASCL Conferences. The 2024 ASCL Conference on Feb. 21-23, 2024, in San Antonio, Texas, welcomed over 280 prominent researchers, physicians, healthcare professionals, patient advocates, and students from across the globe to address cancer health disparities among Latinos. Conference sponsors included: platinum supporters Amgen, AstraZeneca, Bristol Myers Squibb, Genentech, and Gilead; silver supporters GMaP Region 3, ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Demographics and Public Policy: Implications for Latino Cancer
Dr. Elena V. Rios is President & CEO of the National Hispanic Medical Association (NHMA) and president of NHMA’s National Hispanic Health Foundation. Inequity in the healthcare system Dr. Rios’s presentation began by focusing on the changing demographics in the US. By 2035, Latino individuals will make up 1 out of every 4 Americans, meaning that the future of the country is intertwined in the Latino experience. The current 63 million Latino individuals in the US make up 19% of the population; however, only 9% of oncologists are Latino, and only 1/3 of those are women. This is important in light of the high ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Residence in a Latino Enclave and Clinical Outcomes in Texas Children with Acute Lymphoblastic Leukemia
Dr. Jeremy Schraw is an Assistant Professor in the Division of Hematology-Oncology, Department of Pediatrics, at Baylor College of Medicine. Dr. Schraw began by pointing out the higher incidence of acute lymphoblastic leukemia (ALL) among Latino children, and the poorer overall survival (OS) following diagnosis. Social determinants of health likely contribute to these disparities. In fact, children living in Latino enclaves, defined as neighborhoods with a high proportion of Latino residents, recent immigrants, and linguistically isolated households, have poorer OS after diagnosis of ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Latino Cancer Survivors’ Quality of Life and Survivorship Care
Dr. Kristi D. Graves is a tenured Professor of Oncology, Cancer Prevention and Control Program leader at the Lombardi Comprehensive Cancer Center, and Associate Dean for Faculty Development at Georgetown University Medical Center. Latino cancer survivorship Dr. Graves’s presentation began by discussing cancer survivorship across the cancer continuum. The National Cancer Institute’s (NCI) Office of Cancer Survivorship states that “an individual is considered a cancer survivor from the time of diagnosis through the balance of life. There are many types of survivors, including those living with cancer and those ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Adapting NCI’s Clinical Trials System to a Changed Clinical Research Environment
Dr. James H. Doroshow is Deputy Director for Clinical and Translational Research at the National Cancer Institute (NCI). This plenary session occurred at 8:30 am., Thursday, Feb. 22, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. COVID’s impact on cancer clinical trials Dr. Doroshow’s presentation began by discussing the initial and continuing effects of the pandemic environment on cancer clinical trials. From the start of the pandemic, several aspects of clinical trials were altered, including informed consent and in-person study activities. One major ...
